Physician profile
Andreas J Chen
NPI 1245673938
$16,348.95
in general payments reported to CMS, 2019-2025
11 companies · $2,058 in 2025
The $2,058 reported for 2025 was more than what 83% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,252 · 2020: $3,223 · 2021: $1,337 · 2022: $6,071 · 2023: $1,222 · 2024: $186 · 2025: $2,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,459 · Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,458.53 |
| Food and Beverage | $1,007.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $4,341.58 | 2019-2023 | |
| Trimed, INC. | $3,245.91 | 2020-2025 | |
| Arthrex, INC. | $2,956.36 | 2022 | |
| Axogen | $2,661.18 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $1,165.02 | 2022 | |
| Medical Device Business Services, INC. | $882.46 | 2023 | |
| Integra Lifesciences Corporation | $513.61 | 2019 | |
| Depuy Synthes Sales INC. | $343.64 | 2019-2024 | Tfn-Advance, Na, Fibergraft Aeridyan Matrix |
| Stryker Corporation | $127.78 | 2024 | Gamma |
| Endo Pharmaceuticals INC. | $94.84 | 2019 | |
| Amgen INC. | $16.57 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.